# K131929: Surveyor Central Station

- Pathway: 510(k) (Abbreviated)
- Applicant: Mortara Instrument, Inc.
- Decided: Dec 3, 2013 after 159 days
- Product code: MHX (Monitor, Physiological, Patient(With Arrhythmia Detection Or Alarms))
- Device class: 2
- Regulation: 21 CFR 870.1025
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 3 generations back to K933143 (1994). 6 ancestors in all.
6 later devices descend from it; 2 cite it directly.
0 of 13 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K060135: Mortara Surveyor Telemetry Central Station, Mortara Instrument, Inc. (2006) Summary page 1.
- K082946: Mortara Eli 350 Electrocardiograph, Mortara Instrument, Inc. (2008) Summary page 1.

## Most influential descendants
- K133973: Tempus Pro with Enhanced Features (2014), 3 descendants of its own
- K170567: Tempus Pro Patient Monitor (2017), 2 descendants of its own
- K173768: Tempus Pro Patient Monitor (2018), 1 descendant of its own
- K141811: Mortara Monitoring Waveform Viewer (2014), 1 descendant of its own
- K222586: Mural Clinical Viewer (2022), 0 descendants of its own

## Indications for use
The Surveyor Central System is indicated for use: * In a clinical setting, by qualified medical professionals, properly trained for patient monitoring and use of the system. Continuous analysis is provided for all patients. The personnel must be experienced in cardiovascular problematic situations and emergency procedures or pathologies related to cardiac involvements. * Centralized monitoring through a network of patients in Coronary Care Units, Intensive Care Units, Ambulatory Care Units (Telemetry Units), Step-Down Units, Operating Rooms, Emergency Departments and Surgical Centers. Evaluation of adult and pediatric patients with symptoms suggesting arrhythmia. Detected arrhythmias create an audiovisual alarm according to the alarm profile. * Chest Pain Evaluation. * Evaluation of patients with pacemakers. * Evaluation of a patient's response after resuming occupational or recreational activities (e.g., after MlI. or cardiac surgery.) * Evaluation of monitored parameters documenting therapeutic Interventions in individual patients or groups of patients. * Clinical and epidemiological research studies.

Source page: https://510kreport.com/device/K131929
Methodology: https://510kreport.com/methodology